Shares of the biotech company Gilead Sciences experienced a significant drop of almost 10% in early trading following the announcement of a failed trial for their widely-used cancer treatment, Trodelvy,…
Health-care companies experienced a resurgence as traders showed renewed interest in some of the growth stocks that previously led the market before a recent downturn. Eli Lilly Announces Retirement Plans…
Swiss pharmaceutical firm Novartis has announced the completion of the spinoff of its generics and biosimilars business. Starting from Wednesday, the division will trade separately under the name Sandoz. This…
The pharmaceutical industry's quest to dominate the lucrative market for new obesity medicines may face a formidable challenger in emerging biotech company Structure Therapeutics. According to initial data, Structure's obesity…
Morgan Stanley has revised its projection for annual sales of weight-loss drugs, estimating it to reach $77 billion. The surge in demand for these medications has exceeded supply and has…